Marianna Prokopi obtained her BSc in Molecular and Cellular Biology and MSc by Research in Biochemistry from University of Kent. She then attended the London School of Hygiene and Tropical Medicine for her second MSc degree in Medical Microbiology. She received her PhD from the Cardiovascular Division, School of Medicine at King's College London, UK for her work on stem cells and proteomics (evaluation of endothelial progenitor cells as therapeutic agents implicating the development of microparticles and the application of proteomics and miRNA-omics). Her research is focused on the Notch inhibitor drug TR4 as well as developing a program using human stem cell microparticles loaded with miRNAs for the treatment or various malignancies. Dr Prokopi has been awarded several scholarships, bursaries and awards among them the JRC King's College London/NHS Trust King's College Hospital PhD Scholarship, the Peter Baker Award for adapting in new technologies (King's College London), the King's College Award Graduate of the Year.